Showing results (1-10 of 585) with videos related to
Sort By:
Pageof 59
Journal of Experimental Therapeutics & Oncology|November 28, 2007
EGFR inhibitor-mediated apoptosis in solid tumorsSanjay Goel, Manuel Hidalgo, Roman Perez-SolerCurrent Oncology Reports|December 6, 2001
Tyrosine kinase inhibitors: a clinical perspectiveSanjay Goel, Sridhar Mani, Roman Perez-SolerExpert Review of Anticancer Therapy|June 25, 2003
Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinaseAnca M Bulgaru, Sridhar Mani, Sanjay Goel, et al.Cancers|May 8, 2020
Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical PracticeAditi P Singh, Elaine Shum, Lakshmi Rajdev, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancerRoman Perez-SolerClinical Lung Cancer|January 11, 2005
Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancerRoman Perez-SolerClinical Lung Cancer|January 24, 2007
Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancerRoman Perez-SolerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Erlotinib: recent clinical results and ongoing studies in non small cell lung cancerRoman Perez-SolerTargeted Oncology|May 20, 2009
Skin toxicities associated with epidermal growth factor receptor inhibitorsTianhong Li, Roman Perez-SolerDrugs|June 21, 2012
Role of erlotinib in the treatment of non-small cell lung cancer: clinical outcomes in wild-type epidermal growth factor receptor patientsBilal Piperdi, Roman Perez-SolerPageof 59